Literature DB >> 15791844

Regulation of histone acetylation and apoptosis by trichostatin in HL-60 cells.

Xingang Li1, Weikai Chen, Junxia Gu, Guohui Cui, Yan Chen.   

Abstract

In order to examine the strong anticancer action and low toxicity of Trichostatin A (TSA), the effect of TSA was examined on the growth inhibition, acetylation of histone H3 and apoptosis in HL-60 cells by employing MTT, immunocytochemical techniques, and Annexin-V-FITC/ PI assay. Our results showed that TSA could inhibit proliferation of HL- 60 cells in a time- and dose-dependent manner, and the IC50 at the 36th h was 100 ng/ml. The apoptosis-inducing effect of TSA on HL-60 cells was also time- and dose-dependent. But it didn't demonstrate apparent apoptosis induction in NPBMNCs within specific dose and time range. Both of the acetylation of histone H3 in HL-60 cells and NPBMNCs increased significantly (P<0.05) after treated with 100 ng/ml TSA for 4 h. However, there was no significant differences between the two groups (P>0.05). It is concluded that TSA can inhibit growth and induce apoptosis of HL-60 cells in a time- and dose-dependent manner, and is able to selectively induce apoptosis in HL-60 cells but does not respond in NPBMNCs under the same conditions. The difference of TSA between HL-60 cells and NPBMNCs can't be explained by the regulation of histone acetylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15791844     DOI: 10.1007/BF02911358

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

Review 1.  Chromatin remodeling and leukemia: new therapeutic paradigms.

Authors:  R L Redner; J Wang; J M Liu
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

2.  Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines.

Authors:  T Suzuki; H Yokozaki; H Kuniyasu; K Hayashi; K Naka; S Ono; T Ishikawa; E Tahara; W Yasui
Journal:  Int J Cancer       Date:  2000-12-15       Impact factor: 7.396

3.  Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway.

Authors:  V Medina; B Edmonds; G P Young; R James; S Appleton; P D Zalewski
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

4.  Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity.

Authors:  C Nervi; U Borello; F Fazi; V Buffa; P G Pelicci; G Cossu
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

5.  Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.

Authors:  D M Vigushin; S Ali; P E Pace; N Mirsaidi; K Ito; I Adcock; R C Coombes
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

6.  Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis.

Authors:  Woo Hyun Park; Chul Won Jung; Joon Oh Park; Kihyun Kim; Won Seog Kim; Young Hyuck Im; Mark H Lee; Won Ki Kang; Keunchil Park
Journal:  Int J Oncol       Date:  2003-05       Impact factor: 5.650

7.  Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy.

Authors:  H Kosugi; M Towatari; S Hatano; K Kitamura; H Kiyoi; T Kinoshita; M Tanimoto; T Murate; K Kawashima; H Saito; T Naoe
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

8.  Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17).

Authors:  H M Amin; S Saeed; S Alkan
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.